Research programme: phosphodiesterase 10 inhibitors - FORUM Pharmaceuticals

Drug Profile

Research programme: phosphodiesterase 10 inhibitors - FORUM Pharmaceuticals

Alternative Names: EVX 001650; PDE10i

Latest Information Update: 10 Apr 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator EnVivo Pharmaceuticals
  • Class
  • Mechanism of Action Phosphodiesterase 10A inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Schizophrenia

Most Recent Events

  • 02 Apr 2014 EnVivo Pharmaceuticals is now called FORUM Pharmaceuticals
  • 07 Nov 2013 No development reported - Preclinical for Schizophrenia in USA (PO)
  • 06 Dec 2011 Preclinical development is ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top